Chemistry Wealth Management’s NVIDIA NVDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.48M Buy
17,401
+297
+2% +$61.1K 0.56% 32
2026
Q1
$2.98M Buy
17,104
+213
+1% +$39.1K 0.52% 34
2025
Q4
$3.15M Sell
16,891
-459
-3% -$85.4K 0.59% 29
2025
Q3
$3.24M Sell
17,350
-806
-4% -$140K 0.62% 27
2025
Q2
$2.87M Buy
18,156
+6,326
+53% +$796K 0.62% 28
2025
Q1
$1.28M Sell
11,830
-303
-2% -$38.4K 0.3% 55
2024
Q4
$1.63M Buy
12,133
+363
+3% +$50K 0.38% 41
2024
Q3
$1.43M Buy
11,770
+272
+2% +$32.1K 0.34% 49
2024
Q2
$1.42M Buy
11,498
+1,708
+17% +$173K 0.37% 45
2024
Q1
$885K Buy
9,790
+110
+1% +$7.97K 0.24% 73
2023
Q4
$479K Buy
9,680
+270
+3% +$12.5K 0.14% 92
2023
Q3
$409K Buy
9,410
+2,550
+37% +$114K 0.14% 96
2023
Q2
$290K Buy
+6,860
New +$228K 0.09% 124

Other funds holding NVDA

Chemistry Wealth Management's NVDA Position: Q2 2026 in Review

Chemistry Wealth Management increased its NVIDIA (NVDA) stake by 1.7% in Q2 2026, buying an estimated $61.1K and bringing the position to 17,401 shares worth $3.48M. The position accounts for 0.56% of the portfolio, ranked #32.

Chemistry Wealth Management first reported a position in NVDA in Q2 2023 and has held it in 13 quarters since. 3,072 funds tracked by Wall St. Rank hold NVDA as of Q2 2026.

  • Chemistry Wealth Management held 17,401 shares of NVIDIA worth $3.48M as of Q2 2026.
  • Chemistry Wealth Management bought 297 NVIDIA shares in Q2 2026, an estimated $61.1K.
  • NVIDIA made up 0.56% of Chemistry Wealth Management's portfolio in Q2 2026, its #32 holding.
  • Chemistry Wealth Management first reported a position in NVIDIA in Q2 2023 and has held it in 13 quarters since.
  • 3,072 funds tracked by Wall St. Rank held NVIDIA as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.